Villa Medical Center Phuket (www.thailandstemcell.com), an innovator in regenerative medicine and stem cell science under Atlantis Bioscience Singapore, has achieved a breakthrough through its partnership with AGEM Bio a biotechnology spin-off from the National University of Singapore (NUS). This collaboration marks a significant step forward in cancer-focused cell therapy, validating the compatibility of Atlantis’s cultured mesenchymal stem cells (MSCs) with AGEM Bio’s non-viral gene delivery platfor…
In a pivotal experiment on April 25, 2024, AGEM Bio successfully transfected Atlantis-derived MSCs using a proprietary method that enabled expression of Green Fluorescent Protein (GFP). The results showed high transfection efficiency, peaking at 70.76% at 230 ng of plasmid concentration. This confirms both the scalability and bio-functionality of Atlantis’s stem cells, setting a new benchmark for therapeutic-grade regenerative products.
Advancing Oncology Through Precision Cell Engineering
Stem cells have long been celebrated for their regenerative capabilities, but their role in oncology is rapidly expanding. MSCs naturally home to tumor environments, making them promising candidates for delivering targeted anti-cancer therapies. By employing AGEM Bio’s non-viral gene transfer technology, Atlantis’s stem cells have been safely modified to function as precision delivery vectors without the genomic risks associated with viral vectors.
This advancement reinforces Atlantis’s strategic emphasis on developing safe and innovative methods for treating solid tumors and complex malignancies. The ability to deliver therapeutic agents directly into tumor microenvironments opens new horizons in targeted cancer therapy.
Scientific Validation Through Global Partnership
The successful outcomes of this project are grounded in rigorous cross-border collaboration. Villa Medical Center Phuket provided the stem cell lines, while AGEM Bio applied its gene delivery technologies, ensuring compatibility and reproducibility across both research environments.
International partnerships such as this one enable harmonization of quality control protocols, improve clinical trial readiness, and drive faster therapeutic development cycles. This achievement demonstrates that Atlantis’s GMP-grade cells can meet global biotech requirements, reinforcing Thailand’s emerging reputation as a biomedical innovation hub.
Excellence in Education and Workforce Training
Villa Medical Center Phuket doesn’t only focus on product development it also prioritizes education and capacity building. The organization has launched a series of training initiatives to support the growth of a skilled workforce across Southeast Asia in the following areas:
– Stem cell biology and differentiation
– GMP-aligned processing and quality systems
– Advanced cryopreservation techniques
– Clinical applications across orthopedics, dermatology, and dentistry
– Ethical and regulatory frameworks for stem cell therapies
These efforts ensure that Southeast Asia’s next generation of biomedical professionals are well-equipped to support the growing demand for stem cell and ATMP-based therapies.
Consistency with STEMGOLD™ Culture Media
The stem cells used in the AGEM Bio collaboration were cultured using STEMGOLD™, a xeno-free, high-efficiency stem cell medium optimized for MSC expansion and viability. Atlantis successfully expanded a single vial of MSCs to over 7.5 billion cells by the fifth passage, maintaining viability above 90%.
This consistency, also mirrored in AGEM Bio’s facilities, speaks to the technical rigor and standardization capabilities of Villa Medical Center Phuket. A stable culture environment like STEMGOLD™ is essential for producing reproducible outcomes in clinical-grade therapies.
Unlocking the Future of Gene-Modified Cell Therapy
The collaboration with AGEM Bio sets the foundation for broader initiatives in precision oncology, such as:
– Engineering MSCs for tumor-specific drug delivery
– Conducting clinical trials targeting solid tumors
– Developing off-the-shelf immunotherapeutic platforms
– Establishing regulatory pathways for transnational ATMP approvals
Villa Medical Center Phuket is actively expanding its role in this field, paving the way for research that could transform cancer treatment through biologically intelligent therapies.
Thailand as a Regional Catalyst for Regenerative Innovation
With this milestone, Thailand continues to strengthen its position as a leader in regenerative healthcare innovation. Villa Medical Center Phuket exemplifies this momentum by delivering GMP-compliant, scientifically validated stem cells ready for clinical and research deployment across borders.
The success of the Atlantis-AGEM Bio collaboration proves that Thailand’s biomedical institutions can participate meaningfully in global breakthroughs, validating the nation’s growing prominence in this field.
Commitment to Safety, Scalability, and Clinical Readiness
Stem cell therapies must meet increasingly strict quality and safety standards to achieve regulatory approval and patient trust. Villa Medical Center Phuket has invested heavily in internal QA/QC infrastructure, ensuring:
– Full traceability and batch documentation
– PIC/S GMP-certified cleanroom manufacturing
– In-house sterility, endotoxin, and mycoplasma testing
– Cell viability and transfection analytics
With these systems in place, Atlantis remains at the forefront of high-performance stem cell product development and deployment.
Villa Medical Center Phuket
Villa Sukhothai, Soi Pasak 8, Choeng Thale,
Thalang District, Phuket, Thailand
Email: atlantisphuket@gmail.com
Phone/WhatsApp: +66 99 301 6969